New York Yankees third baseman Alex Rodriguez remains a hot topic of discussion despite the fact that his club failed to reach the postseason for only the second time in 19 seasons. Recently slapped with 211-game suspension for violating the MLB's drug agreement and labor contract -- a suspension he appealed -- Rodriguez's only goal was to remain a member of the Yankees as long as possible while helping the team qualify for a playoff berth. With the Yankees coming up short in that goal, the attention has shifted to Rodriguez who - according to multiple sources - will now take another course of action in his battle against Major League Baseball.
According to ESPN, Rodriguez is suing the MLB after accusing the league of interfering with his business relationships and contracts. Rodriguez also believes that Tony Bosch - head of the now-defunct Biogenesis Lab -- was paid upwards of $5 million to help Major League Baseball rid themselves of the third baseman. The lawsuit - filed in New York State Supreme Court -- was made public on Friday and as Sports Illustrated notes, the suit seeks unspecified damages while claiming that current MLB Commissioner Bud Selig attempted to destroy the integrity and reputation of Rodriguez as a cover-up for Selig's prior failure and 'tacit approval' of the use of performance-enhancing drugs.
One of 14 players to be hit with a PED-related suspension this season, Rodriguez issued a statement once the lawsuit went public, noting that he believes his legal team will be able to come away with the desired outcome while also indicating that this procedure is separate from his current arbitration hearings.
The entire legal dynamic is very complex, and my legal team is doing what they need to in order to vindicate me and pursue all of my rights.
This matter is entirely separate from the ongoing arbitration proceedings continuing, and for the day to come when I can share my story with the public and my supporters.
At the present time, Major League Baseball has no official comment but that will obviously change once the issue further develops.
© 2024 Latin Times. All rights reserved. Do not reproduce without permission.